NuCana Down 45.2% After the Bell After Resuming Trading; Announces Update for Phase 2 Randomized Colorectal Cancer Study
NuCana在恢復交易後下跌45.2%;宣佈更新第二階段隨機結直腸癌研究
NuCana Down 45.2% After the Bell After Resuming Trading; Announces Update for Phase 2 Randomized Colorectal Cancer Study
NuCana在恢復交易後下跌45.2%;宣佈更新第二階段隨機結直腸癌研究
使用瀏覽器的分享功能,分享給你的好友吧